NCT Number: NCT02984358
Chronic Mycoprotein Consumption and Nucleotide Content in Metabolic Health
Compare chronic (one week) of a 'normal' meat diet with one week of mycoprotein consumption, with or without a reduced nucleotide content, on markers of metabolic health, such as uric acid concentrations, blood glucose control and blood lipid profiles.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–40 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- BMI between 18 and 30
Exclusion criteria
- On medication (except contraception)
- Smokers
- Diagnosed with any metabolic or cardiovascular conditions
- BMI < 18 or > 30
- Dietary restrictions (vegetarians/vegans, etc.)
Treatment and study plan
Low-nucleotide mycoprotein based diet
OtherHigh-nucleotide mycoprotein based diet
OtherPrimary outcomes
-
Serum uric acid concentrations
Time frame: Measured at baseline; days 2, 4 and 6 of the intervention; and after the 1 week intervention (day 8)
Secondary outcomes
-
Glycaemia and serum insulin - insulin sensitivity (oral glucose tolerance test)
Time frame: Measured at baseline and after 1 week intervention (day 8)
-
IL-6
Time frame: Measured at baseline and after 1 week intervention (day 8)
-
24 h blood glucose homeostasis - measured using a Dexcom CGMS
Time frame: Measured 5 days at baseline (habitual data) and 5 days during the intervention (days 3 - 7)
-
Metabolomics (using Nuclear Magnetic Resonance - NMR)
Time frame: Measured at baseline; days 2, 4 and 6 of the intervention; and after the 1 week intervention (day 8)
Sponsors and collaborators
Lead sponsor
University of Exeter
Other
Registry information
Official study title
Effect of Chronic Mycoprotein Consumption, and of Its Nucleotide Content, in Uric Acid Concentrations and Other Markers of Metabolic Health in Adults
Acronym: MYTH
Important dates
- Study start
- 2017
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Dec 6, 2016
- Registry last updated
- Jun 15, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan
NCT06702423
Healthy
London, United Kingdom
View Trial DetailsValidation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
NCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNormative Value for Navicular Drop Test in Older Adults
NCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details